SCHOTT PHARMA : Jefferies gives a Neutral rating -February 13, 2024 at 08:28 am EST

In his latest research note, analyst James Vane-Tempest confirms his recommendation. The broker Jefferies is keeping its Neutral rating. The target price is unchanged and still at EUR 34.30.

Related Keywords

,James Vane Tempest ,Markets ,